Target Name: H2AC11
NCBI ID: G8969
Review Report on H2AC11 Target / Biomarker Content of Review Report on H2AC11 Target / Biomarker
H2AC11
Other Name(s): H2AFP | H2AC17 | HIST1H2AL | H2A.1b | pH2A/f | histone cluster 1, H2ag | H2AC13 | histone H2A/ptl | HIST1H2AI | HIST1H2AM | H2A histone family, member P | Histone H2A type 1 | H2AG | H2A clustered histone 11 | HIST1H2AG | histone 1, H2ag | H2AC16 | H2A1_HUMAN | histone cluster 1 H2A family member g | H2A.1 | HIST1H2AK | Histone H2A/ptl | histone H2A/p | H2AC15 | H2A/p

H2AFP: A Protein in The Placenta, A Key Component of The ECM Implicated in Several Biological Processes

H2AC11, also known as H2AFP, is a protein that is expressed in the human placenta and has been shown to play a role in several important biological processes. The protein is made by the placenta, and it is a key component of the extracellular matrix (ECM). H2AFP has been shown to be involved in several different biological processes, including fetal development, tissue repair, and cancer. As a result, H2AFP has been identified as a potential drug target and biomarker.

One of the key functions of H2AFP is its role in fetal development. The placenta plays a vital role in the development and growth of the fetus, and it is responsible for providing the fetal with the necessary nutrients and oxygen. H2AFP is a key component of the ECM, and it has been shown to help regulate the growth and development of the placenta.

In addition to its role in fetal development, H2AFP is also involved in tissue repair. When the placenta is removed during a surgical procedure, H2AFP has been shown to help stimulate the body's natural healing processes. This may be important for women who have experienced a surgical separation, as it can help reduce the risk of infection and other complications.

H2AFP is also involved in the immune system. It has been shown to play a role in the immune response, and it has been shown to help protect the body against infection. This may be important for people who have weakened immune systems, such as those who are HIV-positive or who have undergone cancer treatment.

In addition to its role in biology, H2AFP has also been shown to be a potential drug target. Its unique structure and the fact that it is only expressed in the placenta make it an attractive target for drug developers. Studies have shown that H2AFP can be targeted by small molecules, and several compounds have been shown to be able to inhibit its activity.

Furthermore, H2AFP has also been shown to be a potential biomarker for several diseases, including cancer. Its expression has been shown to be elevated in the placenta of women with certain types of cancer, and it has also been shown to be a useful biomarker for tracking the effectiveness of cancer treatments.

In conclusion, H2AFP is a protein that is expressed in the human placenta and has been shown to play a number of important roles in biology. Its unique structure and the fact that it is only expressed in the placenta make it an attractive target for drug developers. Furthermore, H2AFP has also been shown to be a potential biomarker for several diseases, including cancer. As a result, H2AFP is a protein that is worth further research as a potential drug target and biomarker.

Protein Name: H2A Clustered Histone 11

Functions: Core component of nucleosome. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling

The "H2AC11 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about H2AC11 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

H2AC12 | H2AC13 | H2AC14 | H2AC15 | H2AC16 | H2AC17 | H2AC18 | H2AC20 | H2AC21 | H2AC25 | H2AC3P | H2AC4 | H2AC6 | H2AC7 | H2AJ | H2AP | H2AX | H2AZ1 | H2AZ1-DT | H2AZ2 | H2AZ2-DT | H2AZP2 | H2BC1 | H2BC10 | H2BC11 | H2BC12 | H2BC12L | H2BC13 | H2BC14 | H2BC15 | H2BC17 | H2BC18 | H2BC20P | H2BC21 | H2BC26 | H2BC27P | H2BC3 | H2BC4 | H2BC5 | H2BC6 | H2BC7 | H2BC8 | H2BC9 | H2BP1 | H2BP2 | H2BP3 | H2BW1 | H2BW2 | H2BW4P | H3-3A | H3-3B | H3-4 | H3-5 | H3-7 | H3C1 | H3C10 | H3C11 | H3C12 | H3C13 | H3C14 | H3C15 | H3C2 | H3C3 | H3C4 | H3C6 | H3C7 | H3C8 | H3P16 | H3P36 | H3P37 | H3P44 | H3P5 | H3P6 | H4C1 | H4C11 | H4C12 | H4C13 | H4C14 | H4C15 | H4C16 | H4C2 | H4C3 | H4C4 | H4C5 | H4C6 | H4C7 | H4C8 | H4C9 | H6PD | HAAO | HABP2 | HABP4 | HACD1 | HACD2 | HACD3 | HACD4 | HACE1 | HACL1 | HADH | HADHA